Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review.
Huang, Jia-Qing; Zheng, Ge-Fan; Hunt, Richard H; Wong, Wai-Man; Lam, Shiu-Kum; Karlberg, Johan; Wong, Benjamin Chun-Yu.
World J Gastroenterol
; 11(18): 2726-32, 2005 May 14.
Artigo em Inglês | MEDLINE | ID: mdl-15884111
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer.
Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.
One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection.
Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection.
Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.